Efficacy and Safety of Longyizhengqi Granule in Treatment of Mild COVID-19 Patients Caused by SARS-CoV-2 Omicron Variant: A Prospective Study

Wang M, Shi J, Zhang K, Hong J, Peng X, Tian Y, Lu W, Li K, Wang Z, Li F, Zhang Z, Mei G

Infection and Drug Resistance 2023, 16:1611-1618

Published Date: 20 March 2023